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Mycobacterium liﬂ  andii causes a fatal frog disease in 
captive anurans. Here we report, to our knowledge, the 
ﬁ  rst epizootic of mycobacteriosis in a European colony of 
clawed frogs (Silurana tropicalis), previously imported from 
a United States biologic supply company. Our ﬁ  ndings sug-
gest the emerging potential of this infection through interna-
tional trade.
M
any species of nontuberculous mycobacteria inhabit 
the environment. Mycobacterium fortuitum, M. che-
lonae, M. marinum, and M. xenopi are some of the my-
cobacteria that infect amphibians, causing subcutaneous 
nodules, edema, and chronic wasting (1). 
The aquatic, pipid frog, Silurana tropicalis, is an 
emerging laboratory model for genetic and embryologic/
ontogenetic research. Although smaller than the related 
Xenopus laevis, S. tropicalis has research advantages: dip-
loidy and brief maturation time make this species ideal for 
genetic analyses over multiple generations (2).
In 2004, Trott et al. characterized a new mycobacterial 
pathogen in pipid frog colonies (3), now named M. liﬂ  andii 
(4). On Middlebrook 7H11 agar supplemented with oleic 
acid, albumin, dextrose, and catalase, M. liﬂ  andii form 
rough, nonpigmented, slightly buff-colored colonies. Vis-
ible colonies develop after 30 to 35 days at 28°C on Löw-
enstein-Jensen (LJ) medium (3). This M. ulcerans–like 
mycobacterium produces a plasmid-encoded toxin, myco-
lactone E, which is less cytopathogenic than mycolactone 
A/B, produced by African M. ulcerans (4). M. liﬂ  andii in-
fection in frogs manifests as cutaneous lesions, coelomitis, 
and bloating, with a high death rate (3).
We investigated an epizootic of M. liﬂ  andii in a colony 
of African tropical clawed frogs (S. tropicalis) in a Euro-
pean research laboratory. With the rising popularity of this 
vertebrate laboratory model and the foreseen establishment 
of stock centers for mutant or transgenic animals, the epi-
zootiology of this emerging disease must be deﬁ  ned so that 
preventive measures may be instituted.
The Study
In November 2004, we began to study an epizootic 
mycobacteriosis in a colony of imported captive S. tropi-
calis, the African tropical clawed frog. The Department of 
Molecular Biomedical Research, Flanders Interuniversity 
Institute for Biotechnology of Ghent University, Belgium, 
had imported S. tropicalis frogs from a supplier in the Unit-
ed States in September 2004. Within 5 weeks, some ani-
mals became lethargic with signs similar to those described 
by Trott et al.: loss of diving reﬂ  ex, bloating, and ulcerative 
skin lesions (3). An average number of 2 deaths each week 
were reported in a colony of 300 specimens. Preliminary 
examination of 2 affected animals did not show chytridio-
mycosis; iridoviral infection; common bacterial infections 
of liver, lungs and kidneys; chlamydophila infection; or in-
testinal parasites.
From November 2004 through April 2005, 19 visually 
affected and visually unaffected specimens of S. tropica-
lis, 2 tadpoles, and 4 tank water samples were selected for 
detailed examination for mycobacteria. The frogs were eu-
thanized and dissected, and selected organs and ﬂ  uid were 
removed aseptically (liver, lungs, gallbladder, gastrointes-
tinal tract, spleen, kidneys, fat body, ovary, oviduct, tibia, 
and coelomic ﬂ  uid). Each of the specimens was divided 
into 2 equal parts, half for histopathologic analysis and half 
for preparation of decontaminated suspensions for culture 
and microscopic examination (3,5–7). Water samples were 
concentrated by ﬁ  ltration as described by Iivanainen et al. 
(7), and suspensions were made from the complete tadpoles 
(6). Further analyses were performed as described for the 
decontaminated frog suspensions. DNA for genetic analy-
ses was extracted from the suspensions and pure cultures 
as described previously (6,8). M. liﬂ  andii was identiﬁ  ed by 
IS2404 nested PCR and sequence analysis of 16S rRNA 
gene (9,10). A combination of 4 genetic typing assays 
(including 3 previously investigated in M. ulcerans) was 
used to type M. liﬂ  andii (3,9,11,12). A ﬂ  owchart of the per-
formed tests is shown in Figure 1.
All visually affected specimens showed positive re-
sults for at least 1 organ and for at least 2 of the following 
tests: microscopy (Ziehl-Neelsen staining), in vitro culti-
vation (LJ medium and charcoal medium), IS2404 nested 
PCR, and histopathologic examination. Of note, all ovarian 
tissue of the 11 visually affected specimens showed posi-
tive results for at least 2 tests. Three of 8 visually unaffect-
ed specimens showed positive results for at least 1 organ 
(including the ovary) and for 1 test. All tadpoles and water 
samples showed negative results for all tests.
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Histopathologic evaluation showed many acid-fast 
bacilli (AFB) in the oviduct lumen (Figure 2). Numerous 
AFB were found in the kidney tubules, on the surface epi-
thelium, and in the lumens of the gallbladder, stomach, 
intestine, and oviduct. Papillary hyperplasia of the gall-
bladder mucosa was marked, and the lamina propria was 
expanded by heterophils and many AFB (Figure 2). Lung 
parenchyma, liver, femur, and tibia were normal and free 
of AFB.
We identiﬁ  ed the causative pathogen as M. liﬂ  andii 
in all frogs: by growth on charcoal medium, by restriction 
fragment length polymorphism, or by sequence analysis. 
Isolate M05–0456 had a similarity value of 100% with M. 
liﬂ  andii (GenBank accession no. AY845224.1). Growth 
on charcoal medium can be considered as an additional 
identiﬁ  cation criterion for M. liﬂ  andii because growth on 
charcoal is better than on LJ medium (3), differentiating 
M. liﬂ  andii from M. ulcerans. Clinical isolates of M. ulcer-
ans are grown readily on LJ medium but never on charcoal 
medium. The antibiogram of strain M04–2878 showed re-
sistance to isoniazid, ethambutol, rifampin, clarithromycin, 
and ethionamide. In each of the genotyping assays, M. li-
ﬂ  andii produced proﬁ  les that were distinct from those of 
M. ulcerans (data not shown). None of the laboratory staff 
who handled the anurans exhibited any signs of a mycobac-
terial disease.
Conclusions
The ﬁ  rst epizootic of M. liﬂ  andii infection was reported 
by Trott et al. in 2004 in pipid frog colonies in the United 
States (3). To our knowledge, our report is the ﬁ  rst account 
of M. liﬂ  andii disease in a colony of captive S. tropicalis 
frogs in Europe. We do not know the prevalence of M. li-
ﬂ  andii infection in the colony, but we believe it was very 
high because 3 of 8 clinically healthy frogs were positive 
for M. liﬂ  andii by at least 1 test.
The genetic and phenotypic identiﬁ  cation of M. liﬂ  an-
dii as causative agent of the epizootic, the fact that cases of 
M. liﬂ  andii infection have not been reported in Europe to 
date, the strikingly similar signs and disease progress (3), 
and the probability that the frogs were imported from the 
same supplier (3) all suggest that some members of the im-
ported S. tropicalis colony were infected with M. liﬂ  andii 
before arrival in Europe. Crowding and stress associated 
with captivity may have contributed to spread of infection 
within the colony. How and where the imported frogs be-
came infected remains unknown (3). Additionally, during 
an extensive study in the Democratic Republic of Congo, 
Portaels (13) isolated 956 mycobacterial strains from the 
environment from Buruli ulcer–endemic regions. Among 
the unknown species, none was characterized as a M. ulcer-
ans–like mycobacterium. To our knowledge, no M. liﬂ  an-
dii infection, in humans or wild anurans, has been reported 
from Africa. We have conﬁ  rmed that all isolates from Bu-
ruli ulcer patients and environmental samples analyzed by 
our laboratory were true M. ulcerans infections and not 
IS2404 PCR-positive M. ulcerans–like mycobacteria (un-
pub. data).
The apparently enzootic character of M. liﬂ  andii in-
fection in different S. tropicalis breeding companies in 
Figure 1. Flowchart of performed tests. ZN, Ziehl-Neelsen staining; 
LJ, Löwenstein-Jensen medium; Middlebrook 7H11 acidiﬁ  ed with 
phosphoric acid, supplemented with sheep blood and charcoal; 
RFLP, restriction fragment length polymorphism; VNTR, variable 
number of tandem repeats; MIRU, mycobacterial interspersed 
repetitive unit.
Figure 2. A) Oviduct, focally expanded by collections of macrophages and yolk (Y) material. Note acid-fast bacilli (AFB) throughout 
specimens, but concentrated at the periphery (Ziehl-Neelsen [ZN] stain ×25). B) High-power magniﬁ   cation of periphery of oviduct 
containing macrophages and Y material; AFB are concentrated at the periphery (ZN stain ×300). C) Gallbladder with papillary hyperplasia 
of the mucosa. Note masses of AFB in the lamina propria (LP) of the mucosa (ZN stain ×50). D) High-power magniﬁ  cation of the LP of the 
gallbladder mucosa showing large numbers of AFB and heterophils (H) (ZN stain ×300).Mycobacterium liﬂ  andii Infection in Silurana tropicalis
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the United States (3,4) and the exchange of transgenic or 
mutant S. tropicalis lines between research laboratories, 
may pose a serious threat for the international research 
community working with this emerging laboratory model. 
Difﬁ  culties in detecting the pathogen in visually unaffected 
specimens and the high infection rate call for urgent efforts 
in the management of this epizootic disease. Thus far, no 
preventive measures or treatment for this amphibian myco-
bacteriosis are known (3,4,14). Resistance to antimycobac-
terial agents by environmental mycobacteria is not unusual 
and has been reported previously (15).
We propose examining the oocytes of newly imported 
frogs as an intervening noninvasive screening method on 
a regular basis, noting that all affected frogs reported in 
both intercontinental epizootics were females (3), oocytes 
from living adult S. tropicalis are easily obtained for re-
search purposes (2), and ovarian tissue was positive for all 
visually affected specimens and for 1 of 3 positive visu-
ally unaffected specimens. However, further studies are 
needed to determine the role of oocytes in the epizootics 
of this emerging frog disease, especially in the evaluation 
of our proposed screening method. To prevent the infection 
of existing stocks with wild-caught frogs of unknown ori-
gin, we further recommend the importation of only certiﬁ  ed 
pathogen-free laboratory-bred specimens from recognized 
biologic suppliers. Recently, Tarigo et al. reported a frog 
mycobacteriosis in an adult female, albino South African 
clawed frog (X. laevis) in a research colony at North Caro-
lina State University (14). The etiologic agent was identi-
ﬁ  ed as M. marinum complex on the basis of mycobacterial 
culture, but genetic analyses were not performed to exclude 
M. liﬂ  andii infection. To avoid further spread of this dis-
ease, every new outbreak of M. liﬂ  andii infection in pipid 
frogs or other anuran species should be reported to relevant 
authorities and research communities. Until more is known 
about this epizootic and its prevention and treatment, cau-
tion must be exercised in transportation, husbandry, and 
human contact with these animals (zoonotic potential). We 
do not know at this stage whether the importation of frogs 
contaminated by M. liﬂ  andii represents a danger for wild 
or autochthonous frogs. Further investigation is required to 
establish this.
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